Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$627M |
| 2 |
Baidu
BIDU
|
+$542M |
| 3 |
iShares MBS ETF
MBB
|
+$492M |
| 4 |
NVIDIA
NVDA
|
+$429M |
| 5 |
Comcast
CMCSA
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
DuPont de Nemours
DD
|
+$635M |
| 3 |
Broadcom
AVGO
|
+$398M |
| 4 |
Eli Lilly
LLY
|
+$394M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.86% |
| 2 | Healthcare | 3.34% |
| 3 | Consumer Discretionary | 2.41% |
| 4 | Financials | 2.35% |
| 5 | Industrials | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8201
PUT
Arbutus Biopharma
ABUS
$958M
| $912K | ﹤0.01% |
273,800
+22,400
| +9% | +$86.4K |
|
|
BGFV
8202
CALL
DELISTED
Big 5 Sporting Goods
BGFV
| $912K | ﹤0.01% |
58,100
-12,100
| -17% | -$170K |
|
8203
CALL
Kilroy Realty
KRC
$4.21B
| $912K | ﹤0.01% |
13,900
+3,600
| +35% | +$223K |
|
|
TA
8204
CALL
DELISTED
TravelCenters of America LLC
TA
| $912K | ﹤0.01% |
33,600
-30,900
| -48% | -$896K |
|
|
ACRE
8205
CALL
Ares Commercial Real Estate
ACRE
$257M
| $911K | ﹤0.01% |
66,400
+37,300
| +128% | +$488K |
|
8206
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$91.8M
| $911K | ﹤0.01% |
10,900
+400
| +4% | +$37.7K |
|
8207
CALL
iShares Latin America 40 ETF
ILF
$3.74B
| $911K | ﹤0.01% |
33,000
-13,900
| -30% | -$393K |
|
8208
CALL
Viper Energy
VNOM
$15.7B
| $911K | ﹤0.01% |
62,600
+35,000
| +127% | +$537K |
|
8209
CALL
Rocket Pharmaceuticals
RCKT
$367M
| $910K | ﹤0.01% |
20,500
-300
| -1% | -$16.5K |
|
8210
Regis Corp
RGS
$68.6M
| $910K | ﹤0.01% |
3,622
+2,556
| +240% | +$559K |
|
8211
CALL
United Microelectronic
UMC
$46.3B
| $910K | ﹤0.01% |
99,900
-106,900
| -52% | -$989K |
|
|
DSKE
8212
DELISTED
Daseke, Inc. Common Stock
DSKE
| $910K | ﹤0.01% |
107,109
-71,300
| -40% | -$437K |
|
8213
iShares MSCI Denmark ETF
EDEN
$191M
| $909K | ﹤0.01% |
9,384
+589
| +7% | +$56.9K |
|
8214
First Trust Japan AlphaDEX Fund
FJP
$260M
| $909K | ﹤0.01% |
+17,005
| New | +$900K |
|
8215
CALL
Home BancShares
HOMB
$6.2B
| $909K | ﹤0.01% |
+33,600
| New | +$807K |
|
8216
KB Financial Group
KB
$41.3B
| $909K | ﹤0.01% |
+18,393
| New | +$765K |
|
8217
PUT
Public Service Enterprise Group
PEG
$37.7B
| $909K | ﹤0.01% |
15,100
-9,000
| -37% | -$519K |
|
8218
PUT
XPEL
XPEL
$1.37B
| $909K | ﹤0.01% |
17,500
+10,700
| +157% | +$576K |
|
8219
PUT
Sabra Healthcare REIT
SBRA
$5.19B
| $908K | ﹤0.01% |
52,300
+26,100
| +100% | +$459K |
|
8220
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$79M
| $907K | ﹤0.01% |
21,409
+9,055
| +73% | +$399K |
|
8221
CALL
Atossa Therapeutics
ATOS
$25.8M
| $906K | ﹤0.01% |
28,633
+25,140
| +720% | +$919K |
|
|
ATCO
8222
CALL
DELISTED
Atlas Corp.
ATCO
| $906K | ﹤0.01% |
66,400
-800
| -1% | -$10.2K |
|
8223
Sierra Bancorp
BSRR
$527M
| $905K | ﹤0.01% |
33,789
+3,327
| +11% | +$83.6K |
|
|
LDL
8224
DELISTED
Lydall, Inc.
LDL
| $905K | ﹤0.01% |
26,843
-6,805
| -20% | -$233K |
|
8225
PUT
Manhattan Associates
MANH
$11.6B
| $904K | ﹤0.01% |
7,700
-13,500
| -64% | -$1.63M |
|
Similar funds
Ken Griffin's Q1 2021 Portfolio in Review
As of Q1 2021, Ken Griffin held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q1 2021 filing shows 3,276 new, 5,445 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
- Ken Griffin added most to Amazon in Q1 2021, an estimated $627M increase.
- Ken Griffin's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
- Ken Griffin fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
- Ken Griffin's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
- Ken Griffin opened 3,276 new positions and closed 1,034 in Q1 2021.
- Ken Griffin's portfolio value rose 6% quarter-over-quarter to $408B.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.